The Gap Between Clinician-led Cell Therapy and Marketed Products: Pilot study of young ventures

Presented at Regulatory Affairs Professionals Society (RAPS) Convergence 1-4 October 2018, Vancouver, BC.  Sets the stage for understanding the evolving landscape of real world evidence (RWE) for development of new drugs, biologics, and medical devices, as well as improvements in safety monitoring and future integrated surveillance systems.

https://angelanjohnson.com/wp-content/uploads/2020/04/2018-Real-World-Evidence-RWE-presentation.pdf

 

Share the Knowledge.

Science and business are about sharing knowledge. I encourage you to use, modify, and adapt my materials for educational and non-commercial purposes. When you do, please remember to acknowledge me, the original author. Please contact me with any questions.

Preferred citation:

Johnson, A.N. [Workshop] What’s the Deal with Real World Evidence in Regulatory Affairs. Regulatory Affairs Professionals Society (RAPS) Convergence 1-4 October 2018, Vancouver, BC. Accessed online at https://angelanjohnson.com/portfolio/real-deal-with-real-world-evidence-rwe/

 

You can download this presentation here.